The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Matthew E. Falagas

Alfa Institute of Biomedical Sciences

Athens

Greece

[email]@tufts.edu

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Alfa Institute of Biomedical Sciences, Athens, Greece. 2005 - 2008
  • Alfa Institute of Biomedical Sciences, Athens, Greece; Department of Medicine, "Henry Dunant" Hospital, United States of America. 2006
  • Alfa HealthCare, Athens, Greece. 2005

References

  1. Linezolid versus glycopeptide or beta-lactam for treatment of Gram-positive bacterial infections: meta-analysis of randomised controlled trials. Falagas, M.E., Siempos, I.I., Vardakas, K.Z. Lancet. Infect. Dis (2008) [Pubmed]
  2. Effect of a policy for restriction of selected classes of antibiotics on antimicrobial drug cost and resistance. Falagas, M.E., Bliziotis, I.A., Michalopoulos, A., Sermaides, G., Papaioannou, V.E., Nikita, D., Choulis, N. J. Chemother (2007) [Pubmed]
  3. Linezolid for the treatment of adults with bone and joint infections. Falagas, M.E., Siempos, I.I., Papagelopoulos, P.J., Vardakas, K.Z. Int. J. Antimicrob. Agents (2007) [Pubmed]
  4. Cost-effectiveness of different study designs: an overlooked parameter in clinical research. Falagas, M.E., Bliziotis, I.A. J. Clin. Epidemiol (2007) [Pubmed]
  5. The diversity of definitions of multidrug-resistant (MDR) and pandrug-resistant (PDR) Acinetobacter baumannii and Pseudomonas aeruginosa. Falagas, M.E., Koletsi, P.K., Bliziotis, I.A. J. Med. Microbiol. (2006) [Pubmed]
  6. Recurrent post-sternotomy mediastinitis. Falagas, M.E., Rosmarakis, E.S. J. Infect. (2006) [Pubmed]
  7. Quinolones for treatment of human brucellosis: critical review of the evidence from microbiological and clinical studies. Falagas, M.E., Bliziotis, I.A. Antimicrob. Agents Chemother. (2006) [Pubmed]
  8. Toxicity of polymyxins: a systematic review of the evidence from old and recent studies. Falagas, M.E., Kasiakou, S.K. Crit. Care (2006) [Pubmed]
  9. 99mTechnetium-ciprofloxacin scintigraphy for the evaluation of spinal infections: a preliminary report. Falagas, M.E., Valotassiou, V.J., Papadouli, D., Papadopoulos, A., Malamitsi, J. Clin. Orthop. Relat. Res. (2006) [Pubmed]
  10. Spondylodiscitis after facet joint steroid injection: a case report and review of the literature. Falagas, M.E., Bliziotis, I.A., Mavrogenis, A.F., Papagelopoulos, P.J. Scand. J. Infect. Dis. (2006) [Pubmed]
  11. Anti-cytomegalovirus prophylaxis in solid-organ transplant recipients. Falagas, M.E., Vardakas, K.Z. Clin. Microbiol. Infect. (2006) [Pubmed]
  12. The use of intravenous and aerosolized polymyxins for the treatment of infections in critically ill patients: a review of the recent literature. Falagas, M.E., Kasiakou, S.K., Tsiodras, S., Michalopoulos, A. Clin. Med. Res (2006) [Pubmed]
  13. A prospective study of services utilization of a hospital-based employee health clinic. Falagas, M.E., Bliziotis, I.A., Soteriades, E.S. Med. Sci. Monit. (2006) [Pubmed]
  14. A comparative study on the cost of new antibiotics and drugs of other therapeutic categories. Falagas, M.E., Fragoulis, K.N., Karydis, I. PLoS. ONE (2006) [Pubmed]
  15. Eighteen years of research on AIDS: contribution of and collaborations between different world regions. Falagas, M.E., Bliziotis, I.A., Kondilis, B., Soteriades, E.S. AIDS Res. Hum. Retroviruses (2006) [Pubmed]
  16. Narrative review: diseases that masquerade as infectious cellulitis. Falagas, M.E., Vergidis, P.I. Ann. Intern. Med. (2005) [Pubmed]
  17. Toxicity after prolonged (more than four weeks) administration of intravenous colistin. Falagas, M.E., Rizos, M., Bliziotis, I.A., Rellos, K., Kasiakou, S.K., Michalopoulos, A. BMC Infect. Dis. (2005) [Pubmed]
  18. Mesh-related infections after hernia repair surgery. Falagas, M.E., Kasiakou, S.K. Clin. Microbiol. Infect. (2005) [Pubmed]
  19. Outcome of infections due to pandrug-resistant (PDR) Gram-negative bacteria. Falagas, M.E., Bliziotis, I.A., Kasiakou, S.K., Samonis, G., Athanassopoulou, P., Michalopoulos, A. BMC Infect. Dis. (2005) [Pubmed]
  20. Estimates of global research productivity in virology. Falagas, M.E., Karavasiou, A.I., Bliziotis, I.A. J. Med. Virol. (2005) [Pubmed]
  21. Irrigation with antibiotic-containing solutions for the prevention and treatment of infections. Falagas, M.E., Vergidis, P.I. Clin. Microbiol. Infect. (2005) [Pubmed]
  22. Nephrotoxicity of intravenous colistin: a prospective evaluation. Falagas, M.E., Fragoulis, K.N., Kasiakou, S.K., Sermaidis, G.J., Michalopoulos, A. Int. J. Antimicrob. Agents (2005) [Pubmed]
 
WikiGenes - Universities